CAS: 2143097-10-1
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | 2-(2,6-dioxopiperidin-3-yl)-4-((2-(2-hydroxyethoxy)ethyl)amino)isoindoline-1,3-dione REF: IN-DA01V367CAS: 2143097-10-1 | 98% | To inquire | Tue 07 Jan 25 |
 | Pomalidomide-PEG2-OH REF: TM-T9383CAS: 2143097-10-1 | 99.98% | 95.00 €~2,767.00 € | Tue 14 Jan 25 |
2-(2,6-dioxopiperidin-3-yl)-4-((2-(2-hydroxyethoxy)ethyl)amino)isoindoline-1,3-dione
CAS:2143097-10-1
Formula:
C17H19N3O6
Purity:
98%
Color and Shape:
Solid
Molecular weight:
361.3493
Ref: IN-DA01V367
| 1g | To inquire | ||
| 25mg | 147.00 € | ||
| 50mg | 247.00 € | ||
| 100mg | 556.00 € | ||
| 250mg | To inquire |
Estimated delivery in United States, on Tuesday 7 Jan 2025
Pomalidomide-PEG2-OH
CAS:2143097-10-1
Pomalidomide-PEG2-OH enables the synthesis of molecules for targeted protein degradation and PROTAC (proteolysis-targeting chimeras) technology.
Formula:
C17H19N3O6
Purity:
99.98%
Color and Shape:
Solid
Molecular weight:
361.35
Ref: TM-T9383
| 1mg | 95.00 € | ||
| 5mg | 185.00 € | ||
| 10mg | 273.00 € | ||
| 25mg | 436.00 € | ||
| 50mg | 621.00 € | ||
| 100mg | 836.00 € | ||
| 200mg | 1,090.00 € |
Estimated delivery in United States, on Tuesday 14 Jan 2025
